Cancer remains one of the most serious health challenges in the world. It occurs when cells in the body begin to grow uncontrollably and form tumors that can spread to other organs. Although modern ...
The morning Gill Costello should have been given the all-clear, she was instead told the cancer had spread. Not just returned ...
Opinion
American Academy of Dermatology Association statement on FDA withdrawing proposed sunlamp regulation
The American Academy of Dermatology Association is disappointed that the Food and Drug Administration (FDA) is withdrawing its proposed rule on sunlamp regulation, which would have restricted ...
The Healthy @Reader's Digest on MSN
Expert dermatologist: Asking your doctor this one question could catch skin cancer earlier
Adding this to an exam can lead to "higher diagnostic accuracy and fewer missed melanomas," according to a specialist MD.
CytomX Therapeutics, Inc. upgraded to speculative Buy on Varseta-M mCRC data. Click for this updated look at CTMX stock and see why I am now bullish.
Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly or monthly despite >90% rating checks as important. Nearly half of trial ...
In 2025, CytomX remained focused on controlling costs and efficiently progressing its pipeline programs. Total operating expense for 2025 was $98.6 million compared to $113.1 million for 2024, a ...
Several new epidemiological studies hint at a possible link between tattoos and cancer. The results are not yet conclusive ...
The company seeks to leverage the benefits of estrogen signaling to prevent age-related diseases and improve the “healthspan" as part of a new ARPA-H program.
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
Brandon Blackstock cause of death, key medical terms explained simply, melanoma signs to watch, prevention steps, and ...
Immatics N.V. (NASDAQ:IMTX) is among the best German stocks to buy according to analysts. On March 5, Immatics N.V.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results